The diagnosis of heritable retinoblastoma can be made clinically in patients who present with bilateral disease or have a positive family history, but a clinical issue arises when a patient presents with unilateral disease, does not undergo enucleation, and a germline RB1 mutation is not identified in normal blood. Here, RB1 is linked to retinoblastoma.